1 Research Department of Infection & Population Health, University College London, London, UK 2 Department of Neurology, Peninsula Medical School, Peninsula College of Medicine and Dentistry, ...

Correspondence to Dr Satoshi Kuwabara, Department of Neurology, Graduate School of Medicine, Chiba University 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan; kuwabara-s{at}faculty.chiba-u.jp While ...

Objective Psychosis of epilepsy (POE) occurs more frequently in temporal lobe epilepsy, raising the question as to whether abnormalities of the hippocampus are aetiologically important. Despite ...

Correspondence to Dr Harry Costello, Institute of Cognitive Neuroscience, University College London, London, UK; harry.costello{at}ucl.ac.uk Background Neuropsychiatric symptoms are common in ...

Objective The term “functional cognitive disorder” (FCD) has been proposed to describe a subjective experience of cognitive dysfunction in the absence of underlying brain pathology. Features of FCD ...

Objective We set out to determine which characteristics and outcomes of stroke are associated with COVID-19. Methods This case-control study included patients admitted with stroke to 13 hospitals in ...

Objective To establish a rigorous, expert-led, evidence-based approach to the evaluation of licensed drugs for repurposing and testing in clinical trials of people with progressive multiple sclerosis ...

1 MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK 2 Lysholm Department of Neuroradiology, National Hospital for ...

1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan 2 Department of Health Science, Nagoya University Graduate School of Medicine 3 Department of Neurology, ...

Background To mimic as closely as possible a randomised controlled trial (RCT) and calibrate the real-world evidence (RWE) studies against a known treatment effect would be helpful to understand if ...

Washington University School of Medicine, Department of Neurology, St Louis, Missouri, USA Dr A Pestronk, Washington University School of Medicine, Department of Neurology, Box 8111, 660 South Euclid ...

Studies among people with multiple sclerosis (pwMS) receiving disease-modifying therapies (DMTs) have provided adequate evidence for an appraisal of COVID-19 vaccination policies among them. To ...